XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities    
Net income $ 2,242.9 $ 1,344.9
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:    
Depreciation and amortization 400.6 362.3
Change in deferred income taxes (279.0) (559.4)
Stock-based compensation expense 159.4 131.2
Net investment (gains) losses (15.8) 14.2
Acquired in-process research and development 110.5 105.0
Other changes in operating assets and liabilities, net of acquisitions and divestitures (1,751.2) 164.1
Other operating activities, net 298.6 168.3
Net Cash Provided by Operating Activities 1,166.0 1,730.6 Close
Cash Flows from Investing Activities    
Purchases of property and equipment (986.3) (668.5)
Proceeds from sales and maturities of short-term investments 41.4 61.5
Purchases of short-term investments (24.4) (23.0)
Proceeds from sales of and distributions from noncurrent investments 70.5 281.9
Purchases of noncurrent investments (117.1) (146.0)
Purchases of in-process research and development (96.5) (235.0)
Other investing activities, net (65.2) 40.3
Net Cash Used for Investing Activities (1,177.6) (688.8) Close
Cash Flows from Financing Activities    
Dividends paid (1,169.2) (1,017.2)
Net change in short-term borrowings (5,204.8) (1,498.0)
Proceeds from issuance of long-term debt 6,452.5 3,958.5
Purchases of common stock 0.0 (750.0)
Other financing activities, net (389.8) (281.0)
Net Cash Provided by (Used for) Financing Activities (311.3) 412.3 Close
Effect of exchange rate changes on cash and cash equivalents (35.5) 24.8 Close
Net increase (decrease) in cash and cash equivalents (358.4) 1,478.9 Close
Cash and cash equivalents at January 1 2,818.6 2,067.0
Cash and Cash Equivalents at March 31 $ 2,460.2 $ 3,545.9